Mark Brosius - 12 Dec 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Dec 2025, 18:52:12 UTC
Prior SEC filing
06 Jun 2025
Next SEC filing
17 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Thanh Nhan Phan For: Brosius, Mark

Key filing fact

Mark Brosius filed Form 4 for INTUITIVE SURGICAL INC (ISRG) on 15 Dec 2025.

Key facts

  • This page summarizes Mark Brosius's Form 4 filing for INTUITIVE SURGICAL INC (ISRG).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 15 Dec 2025, 18:52.

Change

  • Previous filing in this sequence was filed on 06 Jun 2025.
  • Current net transaction value: -$2,359,249.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002010300 Primary reporting owner

Brosius Mark

Relationship
SVP & Chief Mfg and Supply Cha
Address
1020 KIFER ROAD, SUNNYVALE
Signature
By: Thanh Nhan Phan For: Brosius, Mark
Signature date
15 Dec 2025
This filing has been restated. Open the amended filing.

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ISRG transaction

Common Stock

Options Exercise

Transaction value
$358,370
Shares
+4,500
Change %
+496%
Price
$79.64
Shares after
5,407
Date
12 Dec 2025
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$2,463,120
Shares
-4,500
Change %
-83%
Price
$547.36
Shares after
907
Date
12 Dec 2025
Ownership
Direct
Footnotes
F1
ISRG transaction

Common Stock

Sale

Transaction value
$254,499
Shares
-464
Change %
-51%
Price
$548.49
Shares after
443
Date
15 Dec 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISRG transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
$0
Shares
-4,500
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,500
Exercise price
$79.64
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

Footnote F2

Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .